| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
110.04(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $90.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
854 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$71,002 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
1 |
3 |
5 |
5 |
| Total Sell Transactions |
1 |
3 |
8 |
10 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2016-04-01 |
4 |
S |
$75.22 |
$300,879 |
D/D |
(4,000) |
104,358 |
|
- |
|
| Jackson Shirley A |
Director |
• • – |
2016-03-18 |
4 |
OE |
$46.91 |
$70,037 |
D/D |
1,493 |
31,305 |
|
- |
|
| Jackson Shirley A |
Director |
• • – |
2016-03-18 |
4 |
S |
$75.60 |
$93,593 |
D/D |
(1,238) |
29,812 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2016-03-17 |
4 |
AS |
$76.12 |
$1,812,374 |
D/D |
(23,799) |
600,738 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2016-03-15 |
4 |
D |
$76.85 |
$17,655,135 |
D/D |
(229,735) |
624,537 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2016-03-15 |
4 |
OE |
$34.88 |
$11,266,693 |
D/D |
323,013 |
854,272 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2016-03-04 |
4 |
AS |
$75.00 |
$375,000 |
D/D |
(5,000) |
96,806 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2016-02-18 |
4 |
D |
$74.97 |
$249,125 |
D/D |
(3,323) |
98,483 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• – – |
2016-02-05 |
4 |
AS |
$76.14 |
$380,700 |
D/D |
(5,000) |
101,806 |
|
- |
|
| Hanson Bryan C |
EVP & Pres Min Invas Therapies |
• – – |
2016-01-08 |
4 |
AS |
$75.00 |
$375,000 |
D/D |
(5,000) |
106,514 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• – – |
2015-12-04 |
4 |
S |
$78.06 |
$1,070,644 |
D/D |
(13,715) |
108,086 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• – – |
2015-12-04 |
4 |
OE |
$48.70 |
$750,029 |
D/D |
15,401 |
121,801 |
|
- |
|
| Hanson Bryan C |
EVP & Pres Min Invas Therapies |
• – – |
2015-12-01 |
4 |
D |
$76.51 |
$298,925 |
D/D |
(3,907) |
111,514 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• – – |
2015-10-28 |
4 |
D |
$73.54 |
$561,993 |
D/D |
(7,642) |
68,853 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2015-09-15 |
4 |
AS |
$69.43 |
$1,388,656 |
D/D |
(20,000) |
526,824 |
|
- |
|
| Oleary Denise M |
|
– • – |
2015-08-24 |
4 |
OE |
$56.99 |
$310,068 |
D/D |
5,440 |
48,264 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,599 |
89,034 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEAC |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,830 |
32,334 |
|
- |
|
| Hanson Bryan C |
EVP & Pres Min Invas Therapies |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,394 |
115,090 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,966 |
47,298 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,257 |
106,131 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
55,556 |
546,824 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,830 |
29,701 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,547 |
76,104 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,257 |
36,802 |
|
- |
|
700 Records found
|
|
Page 25 of 28 |
|
|
0.75 (0.92%) 
